To Study the Efficacy and Safety of Medtronic 780G Insulin Pump in People With Gastroparesis and Type 1 Diabetes.

Part of paid clinical trials in Indianapolis, Indiana.

Sponsor
Viral N. Shah
Study ID
NCT07287943
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Medtronic 780G AID — DEVICE
    Participants in Medtronic AID treatment group will use it for three months

Study Details

The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.

Key Dates

Start date
Feb 9, 2026
Status verified
Feb 2026
Primary completion
Nov 1, 2026
Completion
Dec 1, 2026

Study Design

Enrollment
34 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Medtronic 780G group
  • No Intervention: Usual care
    Participants will continue either multiple daily injections or non-AID insulin pumps

Primary Outcome Measure

Time in Range (70-180 mg/dL) [ Time Frame: Baseline to 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Indiana University Health, Univeristy hospitalIndianapolisIndiana46202
Zunera Tariq, MD
[email protected]
317-278-0907
Viral Shah, MD
[email protected]
317-278-6017
Viral Shah, MD (PRINCIPAL_INVESTIGATOR)
Zunera Tariq, MD (SUB_INVESTIGATOR)

Find similar trials in Indianapolis, IN

By condition
Type 1 diabetes
By specialty
Endocrinology
By research site
Indiana University Health, Univeristy hospital· Indianapolis, IN

Related Studies